| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046457703 |
| P356 | DOI | 10.1186/AR3700 |
| P932 | PMC publication ID | 3392811 |
| P698 | PubMed publication ID | 22356717 |
| P5875 | ResearchGate publication ID | 221853400 |
| P50 | author | Ian Bruce | Q30348366 |
| M. Yvonne Alexander | Q42883879 | ||
| P2093 | author name string | Sahena Haque | |
| P2860 | cites work | Origins of circulating endothelial cells and endothelial outgrowth from blood | Q24599869 |
| AC133, a novel marker for human hematopoietic stem and progenitor cells | Q28115893 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Endothelial progenitor cells: identity defined? | Q28303395 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction | Q30968626 | ||
| Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity | Q33873733 | ||
| Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors | Q33887795 | ||
| Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
| Molecular and cellular biology of von Willebrand factor | Q34529616 | ||
| Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome. | Q34640128 | ||
| Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans | Q34907048 | ||
| Interferons as antiangiogenic agents | Q34921341 | ||
| Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells | Q35152132 | ||
| Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. | Q35566925 | ||
| Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus | Q35954549 | ||
| Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry | Q36019443 | ||
| Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis | Q36059617 | ||
| Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells | Q36132926 | ||
| Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus | Q36392411 | ||
| Type I interferon in systemic lupus erythematosus and other autoimmune diseases | Q36595839 | ||
| PECAM-1: a multi-functional molecule in inflammation and vascular biology | Q36943068 | ||
| Level of CD14+-endothelial progenitor cells is not associated with coronary artery disease or cardiovascular risk factors | Q36979376 | ||
| VEGF receptor protein-tyrosine kinases: structure and regulation | Q37235450 | ||
| Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia | Q37633958 | ||
| Type I interferons: crucial participants in disease amplification in autoimmunity | Q37666513 | ||
| Endothelial precursors in vascular repair | Q37698702 | ||
| Proteomics: a reality-check for putative stem cells | Q37845016 | ||
| Role of endothelial progenitor cells in the beneficial effects of physical exercise on atherosclerosis and coronary artery disease | Q37847012 | ||
| Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow | Q38335689 | ||
| Proteomic characterization of human early pro-angiogenic cells | Q38504066 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Endothelial-like cells derived from human CD14 positive monocytes. | Q40863903 | ||
| PECAM-1: its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells. | Q40958086 | ||
| Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 | ||
| Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. | Q41936412 | ||
| Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells | Q41940507 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
| Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. | Q42979924 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
| Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women | Q44774810 | ||
| Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers | Q44932451 | ||
| ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload | Q46043843 | ||
| Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety | Q46700940 | ||
| Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE. | Q53355584 | ||
| Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. | Q53582719 | ||
| CD14+CD34 low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors | Q58816263 | ||
| Circulating Inflammatory Endothelial Cells Contribute to Endothelial Progenitor Cell Dysfunction in Patients with Vasculitis and Kidney Involvement | Q61927987 | ||
| Hematopoietic defects in mice lacking the sialomucin CD34 | Q70884364 | ||
| Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| Immune cells mimic the morphology of endothelial progenitor colonies in vitro | Q80065302 | ||
| Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation | Q80281525 | ||
| Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells | Q81110853 | ||
| Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus | Q81517370 | ||
| Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification | Q83233981 | ||
| Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction | Q84071669 | ||
| Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes | Q84572653 | ||
| Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage | Q84763358 | ||
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| stem cell | Q48196 | ||
| endothelial cell | Q11394395 | ||
| P304 | page(s) | 203 | |
| P577 | publication date | 2012-02-20 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Endothelial progenitor cells: a new player in lupus? | |
| P478 | volume | 14 |
| Q37687986 | Aspirin for prevention of preeclampsia in lupus pregnancy |
| Q64258287 | Diabetic endothelial colony forming cells have the potential for restoration with glycomimetics |
| Q51114187 | Endothelial Progenitor Cells as a Marker of Endothelial Dysfunction and Atherosclerosis in Ankylosing Spondylitis: A Cross-Sectional Study. |
| Q90455731 | Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk |
| Q35564348 | Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy |
Search more.